SCHEMBL11625262

SCHEMBL11625262

CCN(Cc1cc(C)cc(Br)c1N)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 6/20 0.54
▸ SIGMAR1 Q99720 3/20 0.54
▸ SLC6A2 P23975 2/20 0.54
▸ SLC6A4 P31645 2/20 0.54
▸ ABCB11 O95342 1/20 0.54
▸ ADORA3 P0DMS8 1/20 0.54
▸ AR P10275 1/20 0.54
▸ PDE4A P27815 1/20 0.54
▸ SLC6A3 Q01959 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ LMNA P02545 2/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ CYP1A2 P05177 3/20 0.44
▸ CYP2C19 P33261 3/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ CYP2C9 P11712 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ TSHR P16473 3/20 0.42
▸ ALDH1A1 P00352 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11618402 0.85 CYP2D6 (0.53) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11619576 0.84 CYP2D6 (0.52) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11622934 0.83 CYP2D6 (0.77) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11619496 0.82 CYP2D6 (0.50) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11617776 0.82 CYP2D6 (0.50) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11623348 0.81 CYP2D6 (0.49) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11617132 0.81 CYP2D6 (0.49) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11258642 0.81 CYP2D6 (0.49) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
SCHEMBL11621099 0.81 CYP2D6 (0.54) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11
Hydrochloric Acid SCHEMBL11260268 0.80 LMNA (0.50) CYP2D6SIGMAR1SLC6A2SLC6A4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 — — WO disclosed
US-4101671-A ANTIULCEROGENICS BOEHRINGER INGELHEIM GMBH (DE) 1978-07-18 — — US disclosed
US-RE29628-E ANTIULCER, SECRETOLYTICS, ANTITUSSIVE BOEHRINGER INGELHEIM GMBH (DT) 1978-05-09 — — US disclosed
US-3950393-A ANTIULCER, ANTISECRETORY, ANTITUSSIVE AGENTS BOEHRINGER INGELHEIM GMBH (DT) 1976-04-13 — — US disclosed
Send feedback